Glaucoma News

WASHINGTON — Real-world data show that patients who underwent combined Hydrus microstent implantation and cataract surgery had improved IOP and were on fewer medications at 12 months.

WASHINGTON — Patients with glaucoma who underwent goniotomy and viscodilation with the Streamline surgical system experienced reductions in IOP and medications, according to a study.

WASHINGTON — Patients with pseudoexfoliation glaucoma treated with iStent plus cataract surgery had sustained IOP reduction at 8 years postop, according to a study.

WASHINGTON — Take-home devices can provide IOP monitoring over longer periods of time and give physicians a better understanding of their patients’ glaucoma progression.

WASHINGTON — Telehealth became a necessity during the COVID-19 pandemic and is likely to continue to play an important role in glaucoma care in the future.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Tom Frinzi, executive chairman of ViaLase, discusses a product in clinical trials for the noninvasive treatment of open-angle glaucoma in a stand-alone procedure.

A good understanding of gonioscopy is a prerequisite to approach minimally invasive glaucoma surgery, according to a specialist speaking at Real World Ophthalmology.

NEW YORK – Heru introduced two new applications to its diagnostic platform, re:Vive 2.0, at Vision Expo East.

Automated deep learning analysis of fundus photographs showed high diagnostic accuracy in determining primary open-angle glaucoma, with increased ability to detect glaucoma earlier than human readers.

NASHVILLE, Tenn. — Patients who underwent MIGS procedures with and without phacoemulsification experienced IOP reductions and low complication rates, according to data from the IRIS Registry.